Willow Biosciences Inc T.WLLW

Alternate Symbol(s): CANSF

Willow Biosciences Inc. is a Canada-based biotechnology company. The Company develops and produces precision fermented functional ingredients for the health and wellness, food and beverage and personal care markets. Its FutureGrown biotechnology platform allows production with sustainability at its core. Its commercial product, Cannabigerol CBG, which is a cannabinoid that has anti-microbial, anti-inflammatory, and antioxidant properties. It also offers BioOxi, a bio-oxidation technology platform. By leveraging BioOxi, commercial partners can revolutionize manufacturing of oxygenated and hydroxylated functional ingredients, such as steroids, polyphenols, oxyterpenes and certain other targeted ingredients produced from such methods. It is also developing BioOxi-based process for production of the generic active pharmaceutical ingredient (API), hydrocortisone, and its derivatives. Its other pipeline products include Ursodeoxycholic acid (UCAC), Astaxanthin, B-carotene and others.

TSX:WLLW - Post by User

Willow Biosciences Inc > Had $30Million less than a year ago, $now $18M

<< Previous

Bullboard Posts

Next >>

Post by Magnum2on Dec 14, 2022 4:38pm

526 Views

Post# 35171817

Had $30Million less than a year ago, $now $18M

a few months ago...blowing cash like mad, saying they have funded 2023 lab work, then what???

The sand is pouring out hard on this one as revenues are minimal, the sector is in a major transition and the Banking access they needed in the U.S. did not get okayed by Biden.
Another 12 months should wipe away many in the sector, doubt these guys survive given todays' plan/news.

DYODD

<< Previous

Bullboard Posts

Next >>

One of the strongest contenders to lead Canada’s cannabis market